Absent benefit of accelerated concomitant chemoradiotherapy
Lancet Oncol
.
2012 Apr;13(4):e136; author reply e136-7.
doi: 10.1016/S1470-2045(12)70085-2.
Epub 2012 Mar 30.
Authors
Robin J Prestwich
,
Mehmet Sen
PMID:
22469117
DOI:
10.1016/S1470-2045(12)70085-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma / therapy*
Chemoradiotherapy / methods*
Female
Head and Neck Neoplasms / therapy*
Humans
Male